Webster Brian Daniel 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Webster Brian Daniel
DirectorSee Remarks
Transactions
- Sale
Common Shares
[F1][F2]2026-01-15$22.80/sh−15,000$342,024→ 394,786 total
Footnotes (2)
- [F1]The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- [F2]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.2800 to $23.1340. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Signature
/s/ Brian Daniel Webster|2026-01-20